The Latest Cardiac and Vascular News
– HealthyU ™ monitors multiple clinical parameters, plus 7-lead ECG and stethoscope integrated into one device – – Allows the patient and provider to connect remotely through an integrated platform – SANTA CLARA, California – ( BUSINESS WIRE ) – At CES’21, HD Medical Inc. today introduces HealthyU ™, an intelligent remote patient monitoring device, in […]
Experienced Neurovascular Device Executive will Lead Commercialization in US, Canada and LATAM YOKNEAM, Israel & FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces James Romero as the company’s President, Americas. Mr. Romero will oversee the growth and […]
Bioheart comfortably and continuously monitors daily activities and provides advanced heart performance data in a user-friendly format LAS VEGAS, Jan. 11, 2021 (GLOBE NEWSWIRE) — CES – Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Bioheart, a personal heart monitor. Designed for individuals diagnosed with or at risk for cardiovascular disease, Bioheart continuously […]
Global heart health leader introduces VitalSight™, its first remote patient monitoring service, and previews a new app that will increase the capabilities of every OMRON connected blood pressure monitor LAKE FOREST, Ill., Jan. 11, 2021 /PRNewswire/ — OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal heart health […]
Novel Technology Brings Potential to Help Millions of Patients with Mitral Valve Regurgitation MENLO PARK, Calif., Jan. 11, 2021 /PRNewswire/ — The Foundry today announced the successful completion of the first-in-human procedure with the Half Moon Medical transcatheter mitral repair technology (TMVr) at Oregon Health and Science University (OHSU) as part of […]
ALAMEDA, Calif., Jan. 11, 2021 /PRNewswire/ — Penumbra, Inc. (the “Company”) (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced certain unaudited preliminary revenue results for the fourth quarter and full year 2020 ahead of its participation at the 39th Annual J.P. Morgan Healthcare Conference on January 11-14, 2021. Q4 Revenue Highlights […]
DuraGraft is a one-time intraoperative treatment used during vascular surgery to reduce the incidence of complications associated with graft failure JUPITER, Fla., Jan. 11, 2021 /PRNewswire/ — Marizyme, Inc. (OTCQB: MRZM), a global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, today announced […]
MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that it has expanded its existing French distribution partnership agreement with MicroPort CRM in France to include both Spain and Portugal. “We are pleased to be represented by MicroPort CRM in France and have been very impressed by […]
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced additional results from the landmark DREAM-HF randomized controlled Phase 3 trial in 537 treated patients with chronic heart failure with reduced left ventricular ejection fraction (HFrEF) who […]
RIDGEFIELD, Conn. and INDIANAPOLIS, Jan. 11, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance® (empagliflozin) which is being investigated as a potential new treatment to reduce the risk of cardiovascular death and hospitalization for heart failure and to slow kidney function decline in adults with […]
